111, Inc. (NASDAQ:YI) Sees Significant Increase in Short Interest

111, Inc. (NASDAQ:YIGet Free Report) was the recipient of a large growth in short interest during the month of October. As of October 15th, there was short interest totalling 74,600 shares, a growth of 82.0% from the September 30th total of 41,000 shares. Based on an average daily trading volume, of 294,600 shares, the short-interest ratio is presently 0.3 days.

111 Price Performance

NASDAQ:YI opened at $0.75 on Monday. 111 has a 1 year low of $0.55 and a 1 year high of $2.49. The stock’s fifty day moving average price is $0.80 and its two-hundred day moving average price is $1.00. The company has a market cap of $64.31 million, a P/E ratio of -1.21 and a beta of 0.39.

111 (NASDAQ:YIGet Free Report) last posted its quarterly earnings data on Thursday, August 29th. The company reported ($0.02) earnings per share (EPS) for the quarter. The company had revenue of $471.21 million during the quarter.

Institutional Investors Weigh In On 111

A hedge fund recently bought a new stake in 111 stock. Deuterium Capital Management LLC purchased a new stake in shares of 111, Inc. (NASDAQ:YIFree Report) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 100,000 shares of the company’s stock, valued at approximately $116,000. Deuterium Capital Management LLC owned about 0.12% of 111 as of its most recent SEC filing. 21.32% of the stock is currently owned by institutional investors.

About 111

(Get Free Report)

111, Inc, together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers.

Featured Stories

Receive News & Ratings for 111 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 111 and related companies with MarketBeat.com's FREE daily email newsletter.